• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

重复肝切除或挽救性肝移植术后复发性肝癌中中性粒细胞与淋巴细胞比值的预测价值

Predictive value of neutrophil-to-lymphocyte ratio in recurrent HCC after repeat hepatectomy or salvage liver transplantation.

作者信息

Chen Jiafeng, Fang Yuan, Tang Zheng, Dong Enfu, Gao Jun, Zhu Guiqi, Kwangwari Pascal, Feng Shanru, Qu Weifeng, Wu Xiaoling, Mao Shengwei, Zhao Qianfu, Wang Yi, Yang Rui, Guan Zhiqi, Chu Tianhao, Bu Yichao, Zhou Jian, Fan Jia, Fu Xiutao, Liu Weiren, Ding Zhenbin, Shi Yinghong

机构信息

Department of Liver Surgery and Transplantation, Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, China.

Research Unit of Liver Cancer Recurrence and Metastasis, Chinese Academy of Medical Sciences, Beijing, China.

出版信息

Hepatol Int. 2025 Feb 22. doi: 10.1007/s12072-025-10786-7.

DOI:10.1007/s12072-025-10786-7
PMID:39985654
Abstract

BACKGROUNDS AND AIMS

Hepatocellular carcinoma (HCC) is the most prevalent type of primary liver cancer, characterized by a high rate of recurrence. This study aims to compare the efficacy and safety of repeat hepatectomy (RH) and salvage liver transplantation (sLT) for recurrent hepatocellular carcinoma (rHCC) and explores the predictive value of neutrophil-to-lymphocyte ratio (NLR) and neutrophil extracellular traps (NETs).

METHODS

In this study, consecutive patients receiving RH (n = 637) or sLT (n = 53) for rHCC within the University of California San Francisco (UCSF) Criteria were recruited. After propensity score matching (PSM), disease-free survival (DFS) and overall survival (OS) were compared utilizing the Kaplan-Meier method. Additionally, the level of neutrophil infiltration and NETs were analyzed by multiplex immunofluorescence.

RESULTS

After PSM, the sLT group demonstrated superior 5-year DFS and OS compared to the RH group (p < 0.001 and p = 0.014). Subgroup analysis demonstrated that NLR > 2.3 was associated with poorer OS (p < 0.001 in the RH group and p = 0.024 in the sLT group) and DFS (p = 0.002 in both groups). Furthermore, we identified that patients in the sLT group are more susceptible to extrahepatic metastasis. In addition, our results revealed that higher infiltration of intratumoral neutrophils was negatively correlated with OS and DFS (p = 0.002 and p = 0.001, respectively), especially in cases with higher NETs level.

CONCLUSIONS

This study indicates that sLT achieves better long-term outcomes than RH for rHCC. NLR and NETs formation are promising prognostic factors for HCC.

摘要

背景与目的

肝细胞癌(HCC)是原发性肝癌最常见的类型,其特点是复发率高。本研究旨在比较复发性肝细胞癌(rHCC)再次肝切除术(RH)和挽救性肝移植(sLT)的疗效和安全性,并探讨中性粒细胞与淋巴细胞比值(NLR)和中性粒细胞胞外诱捕网(NETs)的预测价值。

方法

本研究纳入了在加利福尼亚大学旧金山分校(UCSF)标准范围内接受RH(n = 637)或sLT(n = 53)治疗rHCC的连续患者。经过倾向评分匹配(PSM)后,采用Kaplan-Meier方法比较无病生存期(DFS)和总生存期(OS)。此外,通过多重免疫荧光分析中性粒细胞浸润水平和NETs。

结果

PSM后,sLT组的5年DFS和OS均优于RH组(p < 0.001和p = 0.014)。亚组分析表明,NLR > 2.3与较差的OS(RH组p < 0.001,sLT组p = 0.024)和DFS(两组均为p = 0.002)相关。此外,我们发现sLT组患者更容易发生肝外转移。另外,我们的结果显示,肿瘤内中性粒细胞浸润增加与OS和DFS呈负相关(分别为p = 0.002和p = 0.001),尤其是在NETs水平较高的情况下。

结论

本研究表明,对于rHCC,sLT比RH能取得更好的长期疗效。NLR和NETs形成是HCC有前景的预后因素。

相似文献

1
Predictive value of neutrophil-to-lymphocyte ratio in recurrent HCC after repeat hepatectomy or salvage liver transplantation.重复肝切除或挽救性肝移植术后复发性肝癌中中性粒细胞与淋巴细胞比值的预测价值
Hepatol Int. 2025 Feb 22. doi: 10.1007/s12072-025-10786-7.
2
Locoregional Therapy With Curative Intent Versus Primary Liver Transplant for Hepatocellular Carcinoma: Systematic Review and Meta-Analysis.以治愈为目的的局部区域治疗与肝细胞癌的原位肝移植:系统评价与荟萃分析
Transplantation. 2017 Aug;101(8):e249-e257. doi: 10.1097/TP.0000000000001730.
3
The prognostic significance of preoperative neutrophil-lymphocyte ratio in patients with hepatocellular carcinoma receiving hepatectomy: A systematic review and meta-analysis.术前中性粒细胞与淋巴细胞比值对接受肝切除术的肝细胞癌患者的预后意义:系统评价和荟萃分析。
Int J Surg. 2018 Jul;55:73-80. doi: 10.1016/j.ijsu.2018.05.022. Epub 2018 May 19.
4
Living donor liver transplantation or hepatic resection combined with intraoperative radiofrequency ablation for Child-Pugh A hepatocellular carcinoma patient with Multifocal Tumours Meeting the University of California San Francisco (UCSF) criteria.活体肝移植或肝切除术联合术中射频消融治疗符合加利福尼亚大学旧金山分校 (UCSF) 标准的多灶性肿瘤 Child-Pugh A 期肝细胞癌患者。
J Cancer Res Clin Oncol. 2021 Feb;147(2):607-618. doi: 10.1007/s00432-020-03364-x. Epub 2020 Aug 27.
5
Repeat hepatectomy versus percutaneous ablation for recurrent hepatocellular carcinoma: emphasis on the impact of early or late recurrence.再次肝切除术与经皮消融治疗复发性肝细胞癌:强调早期或晚期复发的影响。
J Cancer Res Clin Oncol. 2023 Nov;149(16):15113-15125. doi: 10.1007/s00432-023-05286-w. Epub 2023 Aug 26.
6
Neutrophil to Lymphocyte Ratio and Platelet to Lymphocyte Ratio as Prognostic Predictors for Hepatocellular Carcinoma Patients with Various Treatments: a Meta-Analysis and Systematic Review.中性粒细胞与淋巴细胞比值及血小板与淋巴细胞比值作为不同治疗方式下肝细胞癌患者预后预测指标的Meta分析与系统评价
Cell Physiol Biochem. 2017;44(3):967-981. doi: 10.1159/000485396. Epub 2017 Nov 27.
7
Salvage liver transplantation versus curative treatment for patients with recurrent hepatocellular carcinoma: A systematic review and meta-analysis.复发性肝细胞癌患者的挽救性肝移植与根治性治疗:一项系统评价和荟萃分析
Eur J Surg Oncol. 2024 Jul;50(7):108427. doi: 10.1016/j.ejso.2024.108427. Epub 2024 May 20.
8
Comparison on the efficacy and prognosis of different strategies for intrahepatic recurrent hepatocellular carcinoma: A systematic review and Bayesian network meta-analysis.不同策略治疗肝内复发性肝细胞癌疗效和预后的比较:系统评价和贝叶斯网状 Meta 分析。
Int J Surg. 2020 Nov;83:196-204. doi: 10.1016/j.ijsu.2020.09.031. Epub 2020 Sep 25.
9
The Role of Easy-to-use Non-invasive Scores in the Assessment of Hepatocellular Carcinoma Prognosis - Data from the Romanian Hepatocellular Carcinoma Registry.易用的非侵入性评分在肝细胞癌预后评估中的作用——来自罗马尼亚肝细胞癌登记处的数据。
J Gastrointestin Liver Dis. 2025 Jun 28;34(2):205-213. doi: 10.15403/jgld-6114.
10
A modified TNM-7 staging system to better predict the survival in patients with hepatocellular carcinoma after hepatectomy.改良的 TNM-7 分期系统可更好地预测肝癌患者肝切除术后的生存情况。
J Cancer Res Clin Oncol. 2013 Oct;139(10):1709-19. doi: 10.1007/s00432-013-1497-y. Epub 2013 Aug 28.

引用本文的文献

1
Predicting post-liver transplantation mortality: a retrospective cohort study on risk factor identification and prognostic nomogram construction.预测肝移植术后死亡率:一项关于危险因素识别和预后列线图构建的回顾性队列研究。
Eur J Med Res. 2025 Aug 20;30(1):772. doi: 10.1186/s40001-025-03021-4.

本文引用的文献

1
Impact of immunosuppressants on tumor pulmonary metastasis: new insight into transplantation for hepatocellular carcinoma.免疫抑制剂对肿瘤肺转移的影响:肝细胞癌移植的新见解
Cancer Biol Med. 2024 Dec 24;21(11):1033-49. doi: 10.20892/j.issn.2095-3941.2024.0267.
2
APASL clinical practice guidelines on systemic therapy for hepatocellular carcinoma-2024.2024年亚太肝脏研究学会肝细胞癌全身治疗临床实践指南
Hepatol Int. 2024 Dec;18(6):1661-1683. doi: 10.1007/s12072-024-10732-z. Epub 2024 Nov 21.
3
AI-powered prediction of HCC recurrence after surgical resection: Personalised intervention opportunities using patient-specific risk factors.
人工智能预测肝癌切除术后复发:利用患者特定的风险因素进行个性化干预的机会。
Liver Int. 2024 Oct;44(10):2724-2737. doi: 10.1111/liv.16050. Epub 2024 Jul 24.
4
Inflammatory indicators such as systemic immune inflammation index (SIII), systemic inflammatory response index (SIRI), neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) as prognostic factors of curative hepatic resections for hepatocellular carcinoma.全身免疫炎症指数(SIII)、全身炎症反应指数(SIRI)、中性粒细胞与淋巴细胞比值(NLR)和血小板与淋巴细胞比值(PLR)等炎症指标作为肝细胞癌根治性肝切除的预后因素。
Hepatobiliary Surg Nutr. 2024 Jun 1;13(3):509-511. doi: 10.21037/hbsn-23-631. Epub 2024 May 20.
5
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.2022 年全球癌症统计数据:全球 185 个国家和地区 36 种癌症的发病率和死亡率全球估计数。
CA Cancer J Clin. 2024 May-Jun;74(3):229-263. doi: 10.3322/caac.21834. Epub 2024 Apr 4.
6
Development of a deep pathomics score for predicting hepatocellular carcinoma recurrence after liver transplantation.开发一种深度病理评分系统,以预测肝移植后肝细胞癌复发。
Hepatol Int. 2023 Aug;17(4):927-941. doi: 10.1007/s12072-023-10511-2. Epub 2023 Apr 8.
7
NETworking with cancer: The bidirectional interplay between cancer and neutrophil extracellular traps.肿瘤网络:癌症与中性粒细胞胞外诱捕网的双向相互作用。
Cancer Cell. 2023 Mar 13;41(3):505-526. doi: 10.1016/j.ccell.2023.02.001. Epub 2023 Feb 23.
8
Hepatocellular carcinoma.肝细胞癌
Lancet. 2022 Oct 15;400(10360):1345-1362. doi: 10.1016/S0140-6736(22)01200-4. Epub 2022 Sep 6.
9
Clinical implications and biological features of a novel postoperative recurrent HCC classification: A multi-centre study.一种新型术后复发性 HCC 分类的临床意义和生物学特征:一项多中心研究。
Liver Int. 2022 Oct;42(10):2283-2298. doi: 10.1111/liv.15363. Epub 2022 Jul 25.
10
Neutrophils as potential therapeutic targets in hepatocellular carcinoma.中性粒细胞作为肝细胞癌潜在的治疗靶点。
Nat Rev Gastroenterol Hepatol. 2022 Apr;19(4):257-273. doi: 10.1038/s41575-021-00568-5. Epub 2022 Jan 12.